Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Celsion Corporation    CLSN

CELSION CORPORATION

(CLSN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Strengths
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Sector Bio Therapeutic Drugs
1st jan.Capitalisation (M$)Investor Rating
CELSION CORPORATION189.73%131
-
GILEAD SCIENCES, INC.7.78%76 967
VERTEX PHARMACEUTICALS-10.07%55 255
WUXI APPTEC CO., LTD.6.65%53 955
REGENERON PHARMACEUTICALS-6.19%46 924
BEIGENE, LTD.23.84%29 313
BIONTECH SE33.75%26 253
GENMAB A/S-15.96%22 028
ARGENX SE14.71%17 226
HUALAN BIOLOGICAL ENGINEERI..1.28%12 057
NEUROCRINE BIOSCIENCES, INC..14.25%10 288
MIRATI THERAPEUTICS, INC.-8.52%10 173
ULTRAGENYX PHARMACEUTICAL I..2.25%9 476
DENALI THERAPEUTICS INC.-14.28%8 610
FATE THERAPEUTICS, INC.-1.33%8 414
ASCENDIS PHARMA A/S-7.08%8 369
More Results
Financials (USD)
Sales 2020 0,50 M - -
Net income 2020 -23,3 M - -
Net Debt 2020 - - -
P/E ratio 2020 -2,82x
Yield 2020 -
Capitalization 131 M 131 M -
Capi. / Sales 2020 263x
Capi. / Sales 2021 -
Nbr of Employees 29
Free-Float 99,2%
Upcoming event on CELSION CORPORATION
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating -
Investor Rating -
Growth (Revenue) -
Valuation -
Finances -
Profitability -
Earnings quality
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus -
7 days EPS revision -
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes